Gene Therapy for the Treatment of Neurological Disorders: Metabolic Disorders.
about
Tailored transgene expression to specific cell types in the central nervous system after peripheral injection with AAV9.Gene therapy for lysosomal storage disorders: recent advances for metachromatic leukodystrophy and mucopolysaccaridosis I.Uncoupling N-acetylaspartate from brain pathology: implications for Canavan disease gene therapy.
P2860
Gene Therapy for the Treatment of Neurological Disorders: Metabolic Disorders.
description
2016 թվականի հունվարին հրատարակված գիտական հոդված
@hy
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
name
Gene Therapy for the Treatment of Neurological Disorders: Metabolic Disorders.
@en
Gene Therapy for the Treatment of Neurological Disorders: Metabolic Disorders.
@nl
type
label
Gene Therapy for the Treatment of Neurological Disorders: Metabolic Disorders.
@en
Gene Therapy for the Treatment of Neurological Disorders: Metabolic Disorders.
@nl
prefLabel
Gene Therapy for the Treatment of Neurological Disorders: Metabolic Disorders.
@en
Gene Therapy for the Treatment of Neurological Disorders: Metabolic Disorders.
@nl
P2860
P1476
Gene Therapy for the Treatment of Neurological Disorders: Metabolic Disorders.
@en
P2093
Dominic J Gessler
Guangping Gao
P2860
P304
P356
10.1007/978-1-4939-3271-9_30
P407
P577
2016-01-01T00:00:00Z